Mahboob, Anber, Sharif Medical and Dental College, Lahore, Pakistan
-
Vol. 12, No. 10, Oct 2021 - Case Reports
Nivolumab, a Double-Edged Sword: A Case Report of Nivolumab-Induced Myasthenia Gravis
Abstract HTML PDF
INFORMATION
MOST READ |
(For the last 12-month published articles)
QUICK LINKS |
|
|
|
|
Submit Manuscript |
|
Editorial Board |
|
|
|
|
|
|
|
Conflict of Interest |
|
|
|
ARTICLE STATISTICS |
Submission to First Decision |
32 Days |
Acceptance Rate |
38% |
Acceptance to Publication |
26 Days |
*Average article statistics from the last 12 months data |
COVID-19 RESEARCH |
The COVID-19 outbreak presents the unprecedented challenge for world public and medical practitioners and health care providers, the post COVID-19 condition (or long COVID) includes long term symptoms which may persist for months or years after SARS-CoV-2 infection. We will consider submissions related to all aspects of COVID-19 and Long COVID, and process the manuscripts in priority. |